iCAD Inc., headquartered in Nashua, New Hampshire, is a medical-device manufacturer. iCAD makes cancer detection and radiation therapy devices. iCAD offers computer aided detection and workflow solutions to support detection of breast, prostate and colorectal cancers.

Company profile
Ticker
ICAD
Exchange
Website
CEO
Michael S. Klein
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
3M • Baxter International • Boston Scientific • Stryker • Becton, Dickinson And • Teleflex • Resmed • Haemonetics • Hill-Rom • Nuvasive ...
Former names
HOWTEK INC
SEC CIK
Corporate docs
Subsidiaries
Xoft, Inc. • Xoft Solutions, LLC • iCad France, LLC • iCad Italy, LLC ...
IRS number
20377419
ICAD stock data
Analyst ratings and price targets
Current price
Average target
$8.00
Low target
$8.00
High target
$8.00
Lake Street
Maintains
$8.00
BTIG
Maintains
$8.00
Investment data
Securities sold
Number of investors
Calendar
15 Aug 22
19 Aug 22
31 Dec 22
Financial summary
Quarter (USD) | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 27.18M | 27.18M | 27.18M | 27.18M | 27.18M | 27.18M |
Cash burn (monthly) | 872.67K | 892.42K | 1.04M | 1.08M | 853.33K | 903.33K |
Cash used (since last report) | 1.47M | 1.5M | 1.75M | 1.82M | 1.43M | 1.52M |
Cash remaining | 25.71M | 25.68M | 25.43M | 25.36M | 25.75M | 25.66M |
Runway (months of cash) | 29.5 | 28.8 | 24.5 | 23.4 | 30.2 | 28.4 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
19 Apr 22 | Klein Michael S | Director stock option Common stock | Grant | Acquire A | No | No | 7.2 | 30,000 | 216K | 30,000 |
18 Mar 22 | Stevens Stacey M | Employee stock option Common Stock | Grant | Acquire A | No | No | 4.15 | 200,000 | 830K | 200,000 |
14 Mar 22 | Stevens Stacey M | Employee stock option Common Stock | Grant | Acquire A | No | No | 3.93 | 200,000 | 786K | 200,000 |
3 Mar 22 | Timothy Norris Irish | Common Stock | Buy | Acquire P | No | No | 4.63 | 5,500 | 25.47K | 5,500 |
Institutional ownership, Q2 2022
46.7% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 67 |
Opened positions | 14 |
Closed positions | 26 |
Increased positions | 12 |
Reduced positions | 33 |
13F shares | Current |
---|---|
Total value | 53.87M |
Total shares | 11.83M |
Total puts | 25K |
Total calls | 17.3K |
Total put/call ratio | 1.4 |
Largest owners | Shares | Value |
---|---|---|
Granahan Investment Management | 2.44M | $9.74M |
AIGH Capital Management | 1.36M | $5.44M |
Portolan Capital Management | 1.1M | $4.39M |
Vanguard | 1.06M | $4.22M |
Pura Vida Investments | 672.99K | $2.69M |
MS Morgan Stanley | 404.61K | $1.62M |
Worth Venture Partners | 380.89K | $1.62M |
BLK Blackrock | 371.42K | $1.49M |
Essex Investment Management | 320.55K | $1.28M |
Greenwood Capital Associates | 225.73K | $903K |
Financial report summary
?Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
accelerate, ASUNo, brought, Daley, delivery, expanded, foot, half, Irvine, Italy, lessee, life, modification, opposed, rent, Sarno, small, square, Stephen, subscription, TheC, trend
Removed:
ASU, Carter, manufacturer, month, remained
Financial reports
Current reports
8-K
Company reports accelerating demand for subscription and cloud-based business models driving long-term recurring revenue opportunities
10 Aug 22
8-K
Submission of Matters to a Vote of Security Holders
22 Jun 22
8-K
Stephen P. Sarno appointed as interim Chief Financial Officer to the Company, effective
31 May 22
8-K
Entry into a Material Definitive Agreement
25 May 22
8-K
Results of Operations and Financial Condition
11 May 22
8-K
Company expects preliminary estimated revenue to be $7.5 million
21 Apr 22
8-K
Departure of Directors or Certain Officers
28 Mar 22
8-K
Launched ProFound AI® Risk, the world’s first clinical decision support tool for short term breast cancer risk estimation
28 Feb 22
8-K
Departure of Directors or Certain Officers
13 Jan 22
8-K
Company expects preliminary estimated Q4 2021 revenues to be between $7.8-$8.0 million
6 Jan 22
Registration and prospectus
424B5
Prospectus supplement for primary offering
4 Mar 21
424B5
Prospectus supplement for primary offering
2 Mar 21
424B5
Prospectus supplement for primary offering
24 Apr 20
424B5
Prospectus supplement for primary offering
31 Mar 20
S-3
Shelf registration
10 Jan 20
S-8
Registration of securities for employees
18 Dec 19
424B5
Prospectus supplement for primary offering
13 Jun 19
424B5
Prospectus supplement for primary offering
12 Jun 19
424B3
Prospectus supplement
20 Feb 19
S-8
Registration of securities for employees
31 Jan 19
Other
SD
Conflict minerals disclosure
9 May 22
SD
Conflict minerals disclosure
28 May 21
SD
Conflict minerals disclosure
27 May 20
EFFECT
Notice of effectiveness
3 Feb 20
CORRESP
Correspondence with SEC
29 Jan 20
UPLOAD
Letter from SEC
14 Jan 20
SD
Conflict minerals disclosure
24 May 19
EFFECT
Notice of effectiveness
15 Feb 19
CORRESP
Correspondence with SEC
12 Feb 19
UPLOAD
Letter from SEC
11 Feb 19
Ownership
SC 13G
ICAD / BlackRock ownership change
8 Jul 22
SC 13G
ICAD / HIRSCHMAN ORIN ownership change
6 Jul 22
3
ICAD / Stephen P Sarno ownership change
7 Jun 22
4
ICAD / Michael S Klein ownership change
21 Apr 22
4/A
ICAD / Stacey M Stevens ownership change
28 Mar 22
4
ICAD / Stacey M Stevens ownership change
23 Mar 22
4
ICAD / Jonathan Go ownership change
16 Mar 22
4
ICAD / Timothy Norris Irish ownership change
3 Mar 22
SC 13G
ICAD / Granahan Investment Management ownership change
13 Feb 22
SC 13G/A
ICAD / Portolan Capital Management ownership change
11 Feb 22
Patents
Utility
System and method for assessing breast cancer risk using imagery
21 Dec 21
This invention provides a system and method for assessing risk of a breast cancer diagnosis based upon imagery of tissue and (optionally) other patient-related factors.
Utility
System and Method for Assessing Breast Cancer Risk Using Imagery
27 May 20
This invention provides a system and method for assessing risk of a breast cancer diagnosis based upon imagery of tissue and (optionally) other patient-related factors.
Utility
Lung segmentation and bone suppression techniques for radiographic images
14 Oct 19
Lung segmentation and bone suppression techniques are helpful pre-processing steps prior to radiographic analyzes of the human thorax, as may occur during cancer screenings and other medical examinations.
Transcripts
2022 Q2
Earnings call transcript
11 Aug 22
2022 Q1
Earnings call transcript
12 May 22
2021 Q4
Earnings call transcript
1 Mar 22
2021 Q3
Earnings call transcript
10 Nov 21
2021 Q2
Earnings call transcript
8 Aug 21
2021 Q1
Earnings call transcript
29 Apr 21
2020 Q4
Earnings call transcript
25 Feb 21
2020 Q3
Earnings call transcript
7 Nov 20
2020 Q2
Earnings call transcript
4 Aug 20
2019 Q4
Earnings call transcript
28 Feb 20
Reddit threads
Daily Discussion Thread - August 10th, 2022
10 Aug 22
Daily Discussion Thread - August 9th, 2022
9 Aug 22
Daily Discussion Thread - May 11th, 2022
11 May 22
Daily Discussion Thread - May 10th, 2022
10 May 22
Daily Discussion Thread - May 9th, 2022
9 May 22
Daily Discussion Thread - April 27th, 2022
27 Apr 22
Daily Discussion Thread - April 26th, 2022
26 Apr 22
Daily Discussion Thread - April 25th, 2022
25 Apr 22
Daily Discussion Thread - February 28th, 2022
28 Feb 22
Daily Discussion Thread - February 25th, 2022
25 Feb 22